| # | Drug | Count |
|---|---|---|
| 0 | BLINATUMOMAB | 172 |
| 1 | LENALIDOMIDE | 80 |
| 2 | DEXAMETHASONE | 77 |
| 3 | DEXAMETHASONE 1.5 MG | 77 |
| 4 | CYCLOPHOSPHAMIDE | 63 |
| 5 | CYCLOPHOSPHAMIDE FOR INJECTION | 63 |
| 6 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 63 |
| 7 | METHOTREXATE SODIUM | 48 |
| 8 | METHOTREXATE | 46 |
| 9 | BORTEZOMIB | 44 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | BLINATUMOMAB | 172 | 0.0160 |
| 1 | INOTUZUMAB OZOGAMICIN | 27 | 0.0090 |
| 2 | CLINDAMYCIN AND BENZOYL PEROXIDE | 1 | 0.0037 |
| 3 | TREOSULFAN | 8 | 0.0029 |
| 4 | CLOFARABINE | 4 | 0.0017 |
| 5 | HALOBETASOL PROPIONATE | 2 | 0.0015 |
| 6 | MITOXANTRONE HYDROCHLORIDE | 9 | 0.0014 |
| 7 | HEPARIN SODIUM AND DEXTROSE | 1 | 0.0014 |
| 8 | COLLAGENASE SANTYL | 2 | 0.0012 |
| 9 | SODIUM IODIDE I 123 | 1 | 0.0011 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 109 |
| 1 | Thalidomide Analog [EPC] | 80 |
| 2 | Alkylating Drug [EPC] | 75 |
| 3 | Folate Analog Metabolic Inhibitor [EPC] | 46 |
| 4 | Proteasome Inhibitor [EPC] | 46 |
| 5 | Nucleoside Metabolic Inhibitor [EPC] | 36 |
| 6 | CD22-directed Immunoconjugate [EPC] | 27 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 20 |
| 8 | Leukocyte Growth Factor [EPC] | 15 |
| 9 | Topoisomerase Inhibitor [EPC] | 15 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD22-directed Immunoconjugate [EPC] | 27 | 0.0090 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 7 | 0.0012 |
| 2 | Hematopoietic Stem Cell Mobilizer [EPC] | 1 | 0.0007 |
| 3 | Proteasome Inhibitor [EPC] | 46 | 0.0004 |
| 4 | Asparagine-specific Enzyme [EPC] | 5 | 0.0004 |
| 5 | Alkylating Drug [EPC] | 75 | 0.0003 |
| 6 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 2 | 0.0003 |
| 7 | Echinocandin Antifungal [EPC] | 2 | 0.0002 |
| 8 | Sigma-1 Agonist [EPC] | 2 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |